T1	Participants 59 93	patients with Alzheimer's disease.
T2	Participants 114 152	patients with Alzheimer's disease (AD)
T3	Participants 348 396	AD patients as compared to age-matched controls.
T4	Participants 449 460	AD patients
T5	Participants 891 903	AD patients.
T6	Participants 950 961	AD patients
